TCIM
LLY icon

TIAA CREF Investment Management’s Eli Lilly LLY Stock Holding History

TIAA CREF Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$589M Sell
4,536,891
-314,313
-6% -$38.2M 0.42% 47
2018
Q4 		$561M Buy
4,851,204
+157,712
+3% +$17.6M 0.44% 44
2018
Q3 		$504M Buy
4,693,492
+1,644,879
+54% +$164M 0.33% 63
2018
Q2 		$260M Buy
3,048,613
+320,878
+12% +$26.4M 0.17% 128
2018
Q1 		$211M Sell
2,727,735
-1,143,331
-30% -$92M 0.14% 149
2017
Q4 		$327M Sell
3,871,066
-456,405
-11% -$38.8M 0.22% 102
2017
Q3 		$370M Sell
4,327,471
-1,440,426
-25% -$118M 0.25% 86
2017
Q2 		$475M Sell
5,767,897
-1,970,354
-25% -$161M 0.33% 65
2017
Q1 		$651M Sell
7,738,251
-331,854
-4% -$26.6M 0.47% 40
2016
Q4 		$594M Buy
8,070,105
+1,538,202
+24% +$115M 0.44% 45
2016
Q3 		$524K Buy
6,531,903
+1,302,546
+25% +$104M 0.33% 68
2016
Q2 		$412M Sell
5,229,357
-1,158,108
-18% -$87.2M 0.32% 70
2016
Q1 		$460M Sell
6,387,465
-1,675,744
-21% -$127M 0.35% 60
2015
Q4 		$679M Sell
8,063,209
-459,000
-5% -$38.1M 0.51% 38
2015
Q3 		$713M Buy
8,522,209
+689,723
+9% +$58.2M 0.56% 35
2015
Q2 		$654M Buy
7,832,486
+3,212,309
+70% +$245M 0.46% 41
2015
Q1 		$336M Buy
4,620,177
+544,351
+13% +$38.8M 0.23% 87
2014
Q4 		$281M Buy
4,075,826
+214,777
+6% +$14.5M 0.2% 114
2014
Q3 		$250M Sell
3,861,049
-1,584,049
-29% -$100M 0.18% 126
2014
Q2 		$339M Buy
5,445,098
+1,380,191
+34% +$82.3M 0.24% 89
2014
Q1 		$239M Buy
4,064,907
+1,214,376
+43% +$67.8M 0.17% 123
2013
Q4 		$145M Sell
2,850,531
-1,101,086
-28% -$55.1M 0.1% 221
2013
Q3 		$199M Buy
3,951,617
+351,852
+10% +$18.4M 0.16% 145
2013
Q2 		$177M Buy
+3,599,765
New +$196M 0.14% 157

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TIAA CREF Investment Management's LLY Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Eli Lilly (LLY) stake by 6.5% in Q1 2019, selling an estimated $38.2M and leaving 4,536,891 shares worth $589M. The position accounts for 0.42% of the portfolio, ranked #47.

TIAA CREF Investment Management first reported a position in LLY in Q2 2013 and has held it in 24 quarters since. The position peaked at $713M in Q3 2015. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • TIAA CREF Investment Management held 4,536,891 shares of Eli Lilly worth $589M as of Q1 2019.
  • TIAA CREF Investment Management sold 314,313 Eli Lilly shares in Q1 2019, an estimated $38.2M.
  • Eli Lilly made up 0.42% of TIAA CREF Investment Management's portfolio in Q1 2019, its #47 holding.
  • TIAA CREF Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Eli Lilly position peaked at $713M in Q3 2015.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.